
25 Sept 2025
Blood cancers are amongst the most complex, with over 230 recognised subtypes of blood cancers, including 128 lymphomas and 109 myeloid tumours. They are difficult to detect because their symptoms are often non-specific and heterogeneous, leading to prolonged diagnostic journeys with multiple consultations.
To address this issue, the SANGUINEÂ project is developing the HemaChip, a quick, minimally invasive, cost-effective, and highly sensitive tool for screening and monitoring.
SANGUINE’s Stakeholder Forum ‘Uniting Forces: Addressing Needs in Blood Cancer Care’, held last October, gathered policymakers, healthcare professionals, researchers, and patient representatives to share perspectives on improving early detection, enhancing quality standards, and strengthening EU policy.
The newly released SANGUINE Stakeholder Forum Report captures these discussions and sets out clear policy recommendations. It provides a roadmap for addressing unmet needs in blood cancer care and ensuring that innovation, awareness, and policy align to improve outcomes across Europe.
The report identifies four main areas for policy action:
·      Early Detection: Adopt risk-adapted diagnostic pathways tailored to symptom clusters and high-risk groups, supported by investment in rapid diagnostic centres.
·      Quality of Care: Embed the Essential Requirements for Quality Cancer Care (ERQCC) into national cancer control strategies and accreditation systems to guarantee access to high-quality services.
·      Awareness & Communication: Co-create targeted awareness campaigns with patients and clinicians to improve recognition of symptoms and reduce delays in diagnosis.
·      Policy Integration: Ensure blood cancers are fully represented in European and national cancer strategies, with dedicated funding and regular multi-stakeholder policy dialogues.
Read the full list of policy recommendations and discover the main discussions. The digital version of the SANGUINE Stakeholder Forum Report is now available for download here, and more information can be found here.